INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT Feb 15, 2022 10:05AM
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology Jan 26, 2022 09:31AM
Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change Oct 13, 2021 10:11AM
Kaleido Biosciences Inc. (KLDO) and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical Trial Aug 10, 2021 07:32AM
Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical Trial Aug 10, 2021 07:30AM


Aug 10, 2021 07:30AM Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical Trial
Jan 11, 2021 08:15AM Magenta Therapeutics (MGTA) Highlights Recent Progress and Expected Timing of 2021 Milestones
Jan 11, 2021 08:00AM Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials